Works matching IS 11732563 AND DT 2024 AND VI 44 AND IP 7
Results: 7
Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Parkinson's Disease: A Systematic Review and Meta-Analysis.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 7, p. 459, doi. 10.1007/s40261-024-01378-8
- By:
- Publication type:
- Article
Current Findings and Potential Mechanisms of KarXT (Xanomeline–Trospium) in Schizophrenia Treatment.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 7, p. 471, doi. 10.1007/s40261-024-01377-9
- By:
- Publication type:
- Article
Real-World Safety and Effectiveness of Letermovir in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation: Final Results of Post-Marketing Surveillance in Japan.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 7, p. 527, doi. 10.1007/s40261-024-01376-w
- By:
- Publication type:
- Article
AVT04: An Ustekinumab Biosimilar.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 7, p. 549, doi. 10.1007/s40261-024-01375-x
- By:
- Publication type:
- Article
Efficacy and Safety of BP02 (Trastuzumab Biosimilar) in HER2-Positive Metastatic Breast Cancer: A Multicenter Phase III Study.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 7, p. 513, doi. 10.1007/s40261-024-01374-y
- By:
- Publication type:
- Article
Radiomic Parameters for the Evaluation of Response to Treatment in Metastatic Colorectal Cancer Patients with Liver Metastasis: Findings from the CAVE-GOIM mCRC Phase 2 Trial.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 7, p. 541, doi. 10.1007/s40261-024-01372-0
- By:
- Publication type:
- Article
Sodium Phenylbutyrate and Tauroursodeoxycholic Acid: A Story of Hope Turned to Disappointment in Amyotrophic Lateral Sclerosis Treatment.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 7, p. 495, doi. 10.1007/s40261-024-01371-1
- By:
- Publication type:
- Article